Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder
Sponsor: Imbrium Therapeutics
Summary
The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol consumption in subjects with alcohol use disorder.
Official title: A Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study to Evaluate Impact of Sunobinop (V117957) on Alcohol Consumption in Subjects Diagnosed With Moderate to Severe Alcohol Use Disorder and Seeking Treatment
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2024-10-14
Completion Date
2026-05
Last Updated
2026-03-05
Healthy Volunteers
No
Conditions
Interventions
Sunobinop
1 tablet taken orally at bedtime
Placebo to match sunobinop
1 tablet taken orally at bedtime
Locations (7)
Belmont Medical Office
Brooklyn, New York, United States
Ohio Clinical Trials
Columbus, Ohio, United States
Inquest Clinical Research
Baytown, Texas, United States
Cebis Usa, Llc
Houston, Texas, United States
Bio Terra Med SRL
Bucharest, Romania
Spitalul Universitar De Urgenta Militar Central "Dr. Carol Davila"
Bucharest, Romania
Cabinet Medical Individual Dr. Andreea Popa
Bucharest, Romania